NCT01164735 2024-08-14
Biomarkers in Tumor Tissue Samples From Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
GOG Foundation
Completed
Clinical Trials
4 trialsNCT00063999 2021-10-19
Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
GOG Foundation
Phase 3 Completed
NCT00027690 2019-07-23
Gefitinib in Treating Patients With Persistent or Recurrent Endometrial Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00006903 2019-03-20
Fulvestrant in Treating Patients With Recurrent, Persistent, or Metastatic Endometrial Cancer
GOG Foundation
Phase 2 Unknown